VNRX
Price:
$0.6
Market Cap:
$55.26M
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2012-03-02
Stock Exchange
AMEX
Ticker
VNRX
According to VolitionRx Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 55.12M. This represents a change of 10.83% compared to the average of 49.74M of the last 4 quarters.
The mean historical Enterprise Value of VolitionRx Limited over the last ten years is 97.39M. The current 55.12M Enterprise Value has changed 5.56% with respect to the historical average. Over the past ten years (40 quarters), VNRX's Enterprise Value was at its highest in in the September 2019 quarter at 207.65M. The Enterprise Value was at its lowest in in the December 2023 quarter at 43.33M.
Average
97.39M
Median
79.69M
Minimum
36.20M
Maximum
172.69M
Discovering the peaks and valleys of VolitionRx Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 270.15%
Maximum Annual Enterprise Value = 172.69M
Minimum Annual Increase = -71.85%
Minimum Annual Enterprise Value = 36.20M
Year | Enterprise Value | Change |
---|---|---|
2023 | 36.20M | -71.85% |
2022 | 128.61M | -13.56% |
2021 | 148.78M | -7.67% |
2020 | 161.13M | -6.69% |
2019 | 172.69M | 270.15% |
2018 | 46.65M | -33.58% |
2017 | 70.24M | -17.49% |
2016 | 85.13M | 14.64% |
2015 | 74.26M | 47.75% |
2014 | 50.26M | 93.48% |
The current Enterprise Value of VolitionRx Limited (VNRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
104.53M
5-year avg
129.48M
10-year avg
97.39M
VolitionRx Limited’s Enterprise Value is less than electroCore, Inc. (72.85M), greater than Conformis, Inc. (18.28M), greater than Evogene Ltd. (2.54M), less than Evolus, Inc. (1.07B), greater than OncoCyte Corporation (43.23M),
Company | Enterprise Value | Market cap |
---|---|---|
72.85M | $79.43M | |
18.28M | $17.88M | |
2.54M | $11.21M | |
1.07B | $1.04B | |
43.23M | $48.82M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like VolitionRx Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like VolitionRx Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is VolitionRx Limited's Enterprise Value?
What is the highest Enterprise Value for VolitionRx Limited (VNRX)?
What is the 3-year average Enterprise Value for VolitionRx Limited (VNRX)?
What is the 5-year average Enterprise Value for VolitionRx Limited (VNRX)?
How does the current Enterprise Value for VolitionRx Limited (VNRX) compare to its historical average?